<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Oncosil Medical Ltd — News on 6ix</title>
<link>https://6ix.com/company/oncosil-medical-ltd</link>
<description>Latest news and press releases for Oncosil Medical Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 18 Mar 2026 02:10:04 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/oncosil-medical-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836689478dffbe2df15ec77.webp</url>
<title>Oncosil Medical Ltd</title>
<link>https://6ix.com/company/oncosil-medical-ltd</link>
</image>
<item>
<title>Security Class Reinstatement to Quotation - OSLOE</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/security-class-reinstatement-to-quotation-osloe</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/security-class-reinstatement-to-quotation-osloe</guid>
<pubDate>Wed, 18 Mar 2026 02:10:04 GMT</pubDate>
<description>Security Class Reinstatement to Quotation - OSLOE</description>
</item>
<item>
<title>Security Class Suspension from Quotation</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/security-class-suspension-from-quotation-10</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/security-class-suspension-from-quotation-10</guid>
<pubDate>Wed, 11 Mar 2026 02:41:06 GMT</pubDate>
<description>Security Class Suspension from Quotation</description>
</item>
<item>
<title>Appendix 4D and Half Year Accounts</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/appendix-4d-and-half-year-accounts-49</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/appendix-4d-and-half-year-accounts-49</guid>
<pubDate>Tue, 24 Feb 2026 03:54:17 GMT</pubDate>
<description>Appendix 4D and Half Year Accounts</description>
</item>
<item>
<title>CEO Remuneration Update</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/ceo-remuneration-update</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/ceo-remuneration-update</guid>
<pubDate>Thu, 12 Feb 2026 03:38:15 GMT</pubDate>
<description>CEO Remuneration Update</description>
</item>
<item>
<title>Capital Raising Presentation</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/capital-raising-presentation-26</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/capital-raising-presentation-26</guid>
<pubDate>Tue, 03 Feb 2026 05:14:03 GMT</pubDate>
<description>Capital Raising Presentation</description>
</item>
<item>
<title>Prospectus</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/prospectus-68</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/prospectus-68</guid>
<pubDate>Tue, 03 Feb 2026 05:13:03 GMT</pubDate>
<description>Prospectus</description>
</item>
<item>
<title>$8.0 million Capital Raise for Ongoing Commercial Expansion</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/dollar80-million-capital-raise-for-ongoing-commercial-expansion</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/dollar80-million-capital-raise-for-ongoing-commercial-expansion</guid>
<pubDate>Tue, 03 Feb 2026 05:13:03 GMT</pubDate>
<description>$8.0 million Capital Raise for Ongoing Commercial Expansion</description>
</item>
<item>
<title>Quarterly Activities/Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-118</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-118</guid>
<pubDate>Fri, 30 Jan 2026 03:53:24 GMT</pubDate>
<description>Quarterly Activities/Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/trading-halt-817</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/trading-halt-817</guid>
<pubDate>Fri, 30 Jan 2026 03:27:08 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>OncoSil receives $1.84m R&D tax incentive</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/oncosil-receives-dollar184m-randd-tax-incentive</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/oncosil-receives-dollar184m-randd-tax-incentive</guid>
<pubDate>Wed, 07 Jan 2026 07:23:03 GMT</pubDate>
<description>OncoSil receives $1.84m R&D tax incentive</description>
</item>
<item>
<title>OSPREY Analysis Shows Survival Benefit for OncoSil Patients</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/osprey-analysis-shows-survival-benefit-for-oncosil-patients</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/osprey-analysis-shows-survival-benefit-for-oncosil-patients</guid>
<pubDate>Wed, 03 Dec 2025 03:54:19 GMT</pubDate>
<description>OSPREY Analysis Shows Survival Benefit for OncoSil Patients</description>
</item>
<item>
<title>Response to ASX Aware Letter</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/response-to-asx-aware-letter-77</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/response-to-asx-aware-letter-77</guid>
<pubDate>Mon, 29 Sep 2025 06:32:03 GMT</pubDate>
<description>Response to ASX Aware Letter</description>
</item>
<item>
<title>Positive Preliminary Results from PANCOSIL Phase 1-2 Study</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/positive-preliminary-results-from-pancosil-phase-1-2-study</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/positive-preliminary-results-from-pancosil-phase-1-2-study</guid>
<pubDate>Thu, 18 Sep 2025 03:23:28 GMT</pubDate>
<description>Positive Preliminary Results from PANCOSIL Phase 1-2 Study</description>
</item>
<item>
<title>Appendix 4E and Annual Report</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/appendix-4e-and-annual-report-102</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/appendix-4e-and-annual-report-102</guid>
<pubDate>Fri, 29 Aug 2025 06:52:19 GMT</pubDate>
<description>Appendix 4E and Annual Report</description>
</item>
<item>
<title>Completion of Recruitment in TRIPP-FFX Clinical Trial</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/completion-of-recruitment-in-tripp-ffx-clinical-trial</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/completion-of-recruitment-in-tripp-ffx-clinical-trial</guid>
<pubDate>Wed, 23 Jul 2025 02:49:31 GMT</pubDate>
<description>Completion of Recruitment in TRIPP-FFX Clinical Trial</description>
</item>
<item>
<title>Completion of Recruitment in PANCOSIL Study</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/completion-of-recruitment-in-pancosil-study</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/completion-of-recruitment-in-pancosil-study</guid>
<pubDate>Fri, 04 Jul 2025 02:44:15 GMT</pubDate>
<description>Completion of Recruitment in PANCOSIL Study</description>
</item>
<item>
<title>OSL announces $8.7m capital raise to drive commercialisation</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/osl-announces-dollar87m-capital-raise-to-drive-commercialisation</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/osl-announces-dollar87m-capital-raise-to-drive-commercialisation</guid>
<pubDate>Mon, 26 May 2025 04:38:12 GMT</pubDate>
<description>OSL announces $8.7m capital raise to drive commercialisation</description>
</item>
<item>
<title>Consolidation/Split - OSL</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/consolidationsplit-osl</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/consolidationsplit-osl</guid>
<pubDate>Thu, 01 May 2025 06:43:10 GMT</pubDate>
<description>Consolidation/Split - OSL</description>
</item>
<item>
<title>120 German Hospitals entitled to negotiate fee for OncoSil</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/120-german-hospitals-entitled-to-negotiate-fee-for-oncosil</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/120-german-hospitals-entitled-to-negotiate-fee-for-oncosil</guid>
<pubDate>Tue, 04 Feb 2025 02:57:16 GMT</pubDate>
<description>120 German Hospitals entitled to negotiate fee for OncoSil</description>
</item>
<item>
<title>OncoSil Medical Receives MDR Approval</title>
<link>https://6ix.com/company/oncosil-medical-ltd/news/oncosil-medical-receives-mdr-approval</link>
<guid isPermaLink="true">https://6ix.com/company/oncosil-medical-ltd/news/oncosil-medical-receives-mdr-approval</guid>
<pubDate>Tue, 28 Jan 2025 04:18:14 GMT</pubDate>
<description>OncoSil Medical Receives MDR Approval</description>
</item>
</channel>
</rss>